Galapagos News

Galapagos Analyst Ratings

BenzingaApr 1 07:06 ET

Galapagos Analyst Ratings

BenzingaMar 28 06:18 ET

Galapagos Analyst Ratings

BenzingaMar 7 04:17 ET

Galapagos (GLPG) Gets a Hold From RBC Capital

TipRanksFeb 26 20:45 ET

TD Cowen Sticks to Their Buy Rating for Galapagos (GLPG)

TipRanksFeb 23 14:25 ET

Galapagos Analyst Ratings

BenzingaJan 2 11:02 ET

JPMorgan Cuts Galapagos Price Target to $37 From $45, Maintains Neutral Rating

MT NewswiresDec 5, 2023 08:29 ET

Analysts Offer Insights on Healthcare Companies: Galapagos (GLPG), Andlauer Healthcare Group (OtherANDHF) and MoonLake Immunotherapeutics (MLTX)

TipRanksNov 6, 2023 07:14 ET

TD Cowen Keeps Their Buy Rating on Galapagos (GLPG)

TipRanksNov 3, 2023 16:06 ET

Analysts Conflicted on These Healthcare Names: Galapagos (GLPG) and Immunocore Holdings (IMCR)

TipRanksAug 21, 2023 23:40 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Crispr Therapeutics AG (CRSP) and Galapagos (GLPG)

TipRanksAug 14, 2023 10:30 ET

Morgan Stanley Maintains Equal-Weight on Galapagos, Lowers Price Target to $40

BenzingaAug 7, 2023 11:29 ET

Galapagos Analyst Ratings

BenzingaAug 7, 2023 11:28 ET

Morgan Stanley Reaffirms Their Hold Rating on Galapagos (GLPG)

TipRanksAug 7, 2023 10:45 ET

RBC Cuts Price Target on Galapagos to $38 From $41, Keeps Sector Perform Rating

MT NewswiresAug 7, 2023 07:41 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Select Medical (SEM), Travere Therapeutics (TVTX) and Galapagos (GLPG)

TipRanksAug 5, 2023 11:31 ET

Galapagos Analyst Ratings

BenzingaAug 1, 2023 11:20 ET

Morgan Stanley Reiterates Equal-Weight on Galapagos, Maintains $42 Price Target

BenzingaJul 31, 2023 09:27 ET

Galapagos Analyst Ratings

BenzingaJul 31, 2023 09:26 ET

Analysts Offer Insights on Healthcare Companies: Ligand Pharma (LGND), Galapagos (GLPG) and Pharvaris (PHVS)

TipRanksJul 31, 2023 08:40 ET